US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ALPHA COGNITION INC

5.10

+0.600013.33%

Post-market: 5.120.0200+0.39%19:56 EST

Volume:28.73K

Turnover:142.85K

Market Cap:110.88M

PE:-3.84

High:5.20

Open:4.65

Low:4.60

Close:4.50

52wk High:11.54

52wk Low:3.75

Shares:21.74M

Float Shares:15.06M

Volume Ratio:0.44

T/O Rate:0.19%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.3296

EPS(LYR):-2.0195

ROE:-125.65%

ROA:-42.20%

PB:3.27

PE(LYR):-2.53

Loading ...

Overview Company News Filings

Alpha Cognition Grants Equity Awards to Executive Team Under 2025 Incentive Plan

BRIEF-Alpha Cognition Provides 2026 Corporate Update Highlighting Strategic Priorities And 2025 Commercial Execution

Alpha Cognition Announces 2026 Strategy Focused on Expanding ZUNVEYL Prescriber Base, Increasing Long-Term Care Penetration, Initiating New Studies, and Growing International Licensing Opportunities

Alpha Cognition Price Target Maintained With a $18.00/Share by HC Wainwright & Co.

We Think Alpha Cognition (NASDAQ:ACOG) Can Afford To Drive Business Growth

Simply Wall St.

Alpha Cognition CEO Joins Titan Partners Virtual Fireside Chat

Analysts Offer Insights on Healthcare Companies: Co-Diagnostics (CODX), Stevanato Group (STVN) and Alpha Cognition Inc (ACOG)

Alpha Cognition Reports $2.8 Million Revenue and Expanding ZUNVEYL Adoption in Q3 2025

Alpha Cognition Q3 Sales $2.300M Beat $2.033M Estimate

Press Release: Alpha Cognition Inc. Reports Third Quarter 2025 Financial Results and Provides Operational Update

Press Release: Alpha Cognition (Nasdaq: ACOG) to Report Third Quarter 2025 Financial Results and Provide Business Update on Thursday, November 13, 2025

Alpha Cognition Inc. to Release Third Quarter 2025 Financial Results

Alpha Cognition Is Maintained at Buy by HC Wainwright & Co.

Alpha Cognition Inc. : H.c. Wainwright Cuts Target Price to $18 From $20

THOMSON REUTERS

Alpha Cognition Inc. to Present New Clinical Data on ZUNVEYL® (Benzgalantamine) and Cholinesterase Inhibitors at Upcoming Scientific Meetings

Alpha Cognition Inc. to Present New Clinical Data on ZUNVEYL® and Cholinesterase Inhibitors at ASCP Annual Meeting

Alpha Cognition Inc - Pricing of Oversubscribed Underwritten Public Offering of 5,600,000 Common Shares at $6.25 per Share

THOMSON REUTERS

BRIEF-Alpha Cognition Announces Proposed Public Offering Of Common Shares

Alpha Cognition Plans Public Offering

MT Newswires Live

Alpha Cognition announces common stock offering, no amount given

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ACOG/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ACOG","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACOG\",,,,,undefined,":{"symbol":"ACOG","market":"US","secType":"STK","nameCN":"ALPHA COGNITION INC","latestPrice":5.1,"timestamp":1770411600000,"preClose":4.5,"halted":0,"volume":28733,"hourTrading":{"tag":"盘后","latestPrice":5.12,"preClose":5.1,"latestTime":"19:56 EST","volume":253,"amount":1298.29,"timestamp":1770425791552,"change":0.02,"changeRate":0.003922,"amplitude":0.003922},"delay":0,"changeRate":0.13333333333333325,"floatShares":15056000,"shares":21742100,"eps":-1.329564,"marketStatus":"Market Closed","change":0.6,"latestTime":"02-06 16:00:00 EST","open":4.65,"high":5.1999,"low":4.6,"amount":142847.3536389,"amplitude":0.133311,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.329564,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":4.5,"postHourTrading":{"tag":"盘后","latestPrice":5.12,"preClose":5.1,"latestTime":"19:56 EST","volume":253,"amount":1298.29,"timestamp":1770425791552,"change":0.02,"changeRate":0.003922,"amplitude":0.003922},"volumeRatio":0.44254220745032946},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACOG\",,,,,undefined,":{"symbol":"ACOG","floatShares":15056000,"roa":"-42.20%","roe":"-125.65%","lyrEps":-2.019472,"volumeRatio":0.44254220745032946,"shares":21742100,"dividePrice":0,"high":5.1999,"amplitude":0.133311,"preClose":4.5,"low":4.6,"week52Low":3.75,"pbRate":"3.27","psRate":"14.93","week52High":11.54,"institutionHeld":0,"latestPrice":5.1,"eps":-1.329564,"divideRate":0,"volume":28733,"delay":0,"ttmEps":-1.329564,"open":4.65,"prevYearClose":6.5,"prevWeekClose":4.84,"prevMonthClose":4.84,"prevQuarterClose":6.5,"fiveDayClose":4.84,"twentyDayClose":6.56,"sixtyDayClose":6.26},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACOG\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-15","symbol":"ACOG","fiscalQuarterEnding":"2025/03","expectedEps":-0.58,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"post","actualEps":-0.2},{"market":"US","date":"2025-03-31","symbol":"ACOG","fiscalQuarterEnding":"2024/12","expectedEps":-0.48,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"post","actualEps":-0.51}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACOG\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ACOG\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1742274000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ACOG\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ACOG","date":"2026-02-05","current":-3.835844,"percent":0.882353,"low":-15.468353,"twenty":-10.447137,"median":-6.537737,"eighty":-5.967322,"high":-2.141254,"avg":-7.733941,"sd":2.883598,"marketCap":109145362},"quantilePoints":[{"date":"2024-11-15","current":-5.518409,"twenty":-5.518409,"median":-5.518409,"eighty":-3.492116,"marketCap":89218230.86},{"date":"2024-11-22","current":-6.095906,"twenty":-6.0779,"median":-6.040783,"eighty":-5.518409,"marketCap":89580038.69},{"date":"2024-11-29","current":-7.052964,"twenty":-6.126453,"median":-6.040783,"eighty":-5.612398,"marketCap":103759893.65},{"date":"2024-12-06","current":-6.313396,"twenty":-6.313396,"median":-6.095906,"eighty":-5.994414,"marketCap":92879715.89},{"date":"2024-12-13","current":-5.804676,"twenty":-6.309556,"median":-6.047523,"eighty":-5.928174,"marketCap":85395665.51},{"date":"2024-12-20","current":-3.792145,"twenty":-6.289737,"median":-6.03741,"eighty":-5.564347,"marketCap":55788252.01},{"date":"2024-12-27","current":-5.520861,"twenty":-6.27191,"median":-5.988356,"eighty":-5.512882,"marketCap":81220325},{"date":"2025-01-03","current":-6.174218,"twenty":-6.276367,"median":-6.018645,"eighty":-5.517304,"marketCap":90832197},{"date":"2025-01-10","current":-6.228664,"twenty":-6.280824,"median":-6.044156,"eighty":-5.518409,"marketCap":91633187},{"date":"2025-01-17","current":-6.479118,"twenty":-6.381986,"median":-6.114998,"eighty":-5.51988,"marketCap":95317738},{"date":"2025-01-24","current":-6.827574,"twenty":-6.433383,"median":-6.156206,"eighty":-5.546995,"marketCap":100444070},{"date":"2025-01-31","current":-6.533564,"twenty":-6.529208,"median":-6.174218,"eighty":-5.650957,"marketCap":96118728},{"date":"2025-02-07","current":-6.424671,"twenty":-6.533564,"median":-6.22812,"eighty":-5.770729,"marketCap":94516749},{"date":"2025-02-14","current":-6.228664,"twenty":-6.533564,"median":-6.228664,"eighty":-5.853338,"marketCap":91633187},{"date":"2025-02-21","current":-6.860242,"twenty":-6.561876,"median":-6.283111,"eighty":-5.928174,"marketCap":100924664},{"date":"2025-02-28","current":-6.533564,"twenty":-6.583654,"median":-6.313396,"eighty":-5.93555,"marketCap":96118728},{"date":"2025-03-07","current":-5.83665,"twenty":-6.561876,"median":-6.313396,"eighty":-5.93555,"marketCap":85866063},{"date":"2025-03-14","current":-6.130661,"twenty":-6.544453,"median":-6.27751,"eighty":-5.928174,"marketCap":90191406},{"date":"2025-03-21","current":-6.043547,"twenty":-6.542275,"median":-6.261332,"eighty":-5.928174,"marketCap":88909823},{"date":"2025-03-28","current":-5.782204,"twenty":-6.533564,"median":-6.228664,"eighty":-5.862785,"marketCap":85065074},{"date":"2025-04-04","current":-5.461466,"twenty":-6.533564,"median":-6.206886,"eighty":-5.804122,"marketCap":79938742},{"date":"2025-04-11","current":-4.56399,"twenty":-6.533564,"median":-6.185107,"eighty":-5.723114,"marketCap":66802511},{"date":"2025-04-17","current":-4.651549,"twenty":-6.533564,"median":-6.172541,"eighty":-5.520861,"marketCap":68084094},{"date":"2025-04-25","current":-5.538079,"twenty":-6.522675,"median":-6.13409,"eighty":-5.512882,"marketCap":81060122},{"date":"2025-05-02","current":-6.545003,"twenty":-6.522675,"median":-6.114327,"eighty":-5.512882,"marketCap":95798326},{"date":"2025-05-09","current":-8.099168,"twenty":-6.533564,"median":-6.14155,"eighty":-5.51619,"marketCap":118546423},{"date":"2025-05-16","current":-7.453423,"twenty":-6.566232,"median":-6.174218,"eighty":-5.518409,"marketCap":109094749},{"date":"2025-05-23","current":-11.959073,"twenty":-6.642457,"median":-6.203155,"eighty":-5.518409,"marketCap":139211949},{"date":"2025-05-30","current":-13.885736,"twenty":-6.84282,"median":-6.227575,"eighty":-5.520371,"marketCap":161639650},{"date":"2025-06-06","current":-13.307738,"twenty":-6.982767,"median":-6.228664,"eighty":-5.534635,"marketCap":154911340},{"date":"2025-06-13","current":-13.218285,"twenty":-7.145541,"median":-6.27191,"eighty":-5.555592,"marketCap":153870054},{"date":"2025-06-20","current":-12.296239,"twenty":-7.475313,"median":-6.294194,"eighty":-5.575706,"marketCap":143136796},{"date":"2025-06-27","current":-12.674691,"twenty":-8.112302,"median":-6.314587,"eighty":-5.6646,"marketCap":147542238},{"date":"2025-07-03","current":-14.401807,"twenty":-10.239827,"median":-6.316432,"eighty":-5.72936,"marketCap":167647070},{"date":"2025-07-11","current":-15.138068,"twenty":-12.195778,"median":-6.370225,"eighty":-5.756027,"marketCap":176217657},{"date":"2025-07-18","current":-14.13345,"twenty":-12.475143,"median":-6.394726,"eighty":-5.773634,"marketCap":164523212},{"date":"2025-07-25","current":-13.706832,"twenty":-12.614139,"median":-6.413782,"eighty":-5.782204,"marketCap":159557078},{"date":"2025-08-01","current":-12.537072,"twenty":-12.682948,"median":-6.457339,"eighty":-5.790916,"marketCap":145940259},{"date":"2025-08-08","current":-12.564596,"twenty":-12.682948,"median":-6.490007,"eighty":-5.80426,"marketCap":146260655},{"date":"2025-08-15","current":-11.009504,"twenty":-12.81231,"median":-6.533564,"eighty":-5.817466,"marketCap":128158296},{"date":"2025-08-22","current":-6.669691,"twenty":-12.75451,"median":-6.533564,"eighty":-5.841006,"marketCap":133488100},{"date":"2025-08-29","current":-6.508197,"twenty":-12.713225,"median":-6.532993,"eighty":-5.87803,"marketCap":130255943},{"date":"2025-09-05","current":-6.742363,"twenty":-12.685701,"median":-6.533564,"eighty":-5.924278,"marketCap":134942571},{"date":"2025-09-12","current":-7.897043,"twenty":-12.671939,"median":-6.540496,"eighty":-5.928174,"marketCap":158052496},{"date":"2025-09-19","current":-6.92808,"twenty":-12.652672,"median":-6.544728,"eighty":-5.93555,"marketCap":138659552},{"date":"2025-09-26","current":-6.233657,"twenty":-12.616891,"median":-6.544453,"eighty":-5.939726,"marketCap":124761275},{"date":"2025-10-03","current":-6.007566,"twenty":-12.600377,"median":-6.533564,"eighty":-5.928174,"marketCap":120236255},{"date":"2025-10-10","current":-6.112537,"twenty":-12.575606,"median":-6.533564,"eighty":-5.935025,"marketCap":122337157},{"date":"2025-10-17","current":-7.373231,"twenty":-12.559091,"median":-6.533564,"eighty":-5.935025,"marketCap":147568854},{"date":"2025-10-24","current":-7.300125,"twenty":-12.535696,"median":-6.540496,"eighty":-5.93555,"marketCap":146105706},{"date":"2025-10-31","current":-6.454188,"twenty":-12.527439,"median":-6.544453,"eighty":-5.938649,"marketCap":129175002},{"date":"2025-11-07","current":-5.952892,"twenty":-12.515053,"median":-6.533564,"eighty":-5.951414,"marketCap":119141992},{"date":"2025-11-14","current":-6.40197,"twenty":-12.498539,"median":-6.533564,"eighty":-5.952892,"marketCap":128129897},{"date":"2025-11-21","current":-6.509577,"twenty":-12.446244,"median":-6.533564,"eighty":-5.9536,"marketCap":126756466},{"date":"2025-11-28","current":-6.721724,"twenty":-12.413215,"median":-6.533564,"eighty":-5.956432,"marketCap":130887466},{"date":"2025-12-05","current":-7.112522,"twenty":-12.385692,"median":-6.533564,"eighty":-5.967322,"marketCap":138497202},{"date":"2025-12-12","current":-6.509577,"twenty":-12.296239,"median":-6.533564,"eighty":-5.967322,"marketCap":126756466},{"date":"2025-12-19","current":-5.638656,"twenty":-12.234311,"median":-6.533564,"eighty":-5.956432,"marketCap":109797625},{"date":"2025-12-26","current":-6.978534,"twenty":-12.157245,"median":-6.533564,"eighty":-5.965144,"marketCap":135888150},{"date":"2026-01-02","current":-7.257676,"twenty":-12.071921,"median":-6.535651,"eighty":-5.967322,"marketCap":141323676},{"date":"2026-01-09","current":-7.32467,"twenty":-11.986597,"median":-6.544453,"eighty":-5.971104,"marketCap":142628202},{"date":"2026-01-16","current":-6.498411,"twenty":-11.926045,"median":-6.544728,"eighty":-5.973717,"marketCap":126539045},{"date":"2026-01-23","current":-6.364423,"twenty":-11.782921,"median":-6.542474,"eighty":-5.974375,"marketCap":123929992},{"date":"2026-01-30","current":-5.783809,"twenty":-11.36456,"median":-6.544453,"eighty":-5.974375,"marketCap":112624098},{"date":"2026-02-05","current":-5.605159,"twenty":-10.447137,"median":-6.537737,"eighty":-5.967322,"marketCap":109145362}],"updateTime":1770437423615},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ACOG\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2603593919","title":"Alpha Cognition Grants Equity Awards to Executive Team Under 2025 Incentive Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2603593919","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603593919?lang=en_us&edition=fundamental","pubTime":"2026-01-16 06:28","pubTimestamp":1768516094,"startTime":"0","endTime":"0","summary":"Alpha Cognition Inc. has announced new equity awards for its executive team under the company’s 2025 Stock and Incentive Plan. Chief Executive Officer Michael McFadden received 190,549 restricted stock units  vesting in thirds annually from January 2027 to January 2029, 177,576 stock options vesting over the same period with quarterly installments after the first year, and up to 76,220 performance share units tied to the company’s stock price performance over a two-year period. Chief Operating Officer Lauren D'Angelo was granted 137,195 RSUs with the same vesting schedule, along with 106,545 stock options also vesting over three years. Interim Chief Financial Officer and VP Finance and Accounting Henry Du received 20,579 RSUs and 15,982 stock options, both vesting one-third annually through 2029.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nNDL3wGT9N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACOG","BK4139"],"gpt_icon":0},{"id":"2601538493","title":"BRIEF-Alpha Cognition Provides 2026 Corporate Update Highlighting Strategic Priorities And 2025 Commercial Execution","url":"https://stock-news.laohu8.com/highlight/detail?id=2601538493","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601538493?lang=en_us&edition=fundamental","pubTime":"2026-01-08 06:20","pubTimestamp":1767824421,"startTime":"0","endTime":"0","summary":"BRIEF-Alpha Cognition Provides 2026 Corporate Update Highlighting Strategic Priorities And 2025 Commercial ExecutionJan 8 (Reuters) - Alpha Cognition Inc ACOG.O:ALPHA COGNITION PROVIDES 2026 CORPORATE","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nTUA285X5W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACOG"],"gpt_icon":0},{"id":"2601389710","title":"Alpha Cognition Announces 2026 Strategy Focused on Expanding ZUNVEYL Prescriber Base, Increasing Long-Term Care Penetration, Initiating New Studies, and Growing International Licensing Opportunities","url":"https://stock-news.laohu8.com/highlight/detail?id=2601389710","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601389710?lang=en_us&edition=fundamental","pubTime":"2026-01-08 05:30","pubTimestamp":1767821435,"startTime":"0","endTime":"0","summary":"Alpha Cognition Announces 2026 Strategy Focused on Expanding ZUNVEYL Prescriber Base, Increasing Long-Term Care Penetration, Initiating New Studies, and Growing International Licensing Opportunities. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alpha Cognition Inc. published the original content used to generate this news brief via Business Wire  on January 07, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nNDLbbtGjw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACOG"],"gpt_icon":0},{"id":"2592162666","title":"Alpha Cognition Price Target Maintained With a $18.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2592162666","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592162666?lang=en_us&edition=fundamental","pubTime":"2025-12-19 21:09","pubTimestamp":1766149740,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ACOG/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 19, 2025 08:09 ET (13:09 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACOG"],"gpt_icon":0},{"id":"2589332884","title":"We Think Alpha Cognition (NASDAQ:ACOG) Can Afford To Drive Business Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2589332884","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589332884?lang=en_us&edition=fundamental","pubTime":"2025-12-08 18:24","pubTimestamp":1765189489,"startTime":"0","endTime":"0","summary":"Just because a business does not make any money, does not mean that the stock will go down. For example, although...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-acog/alpha-cognition/news/we-think-alpha-cognition-nasdaqacog-can-afford-to-drive-busi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-acog/alpha-cognition/news/we-think-alpha-cognition-nasdaqacog-can-afford-to-drive-busi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PSQ","USAW.SI","ACOG","NVIW.SI","NQmain","BK4139","TSYW.SI",".IXIC","QLD","SQQQ","QID","USJW.SI","TQQQ","MNQmain"],"gpt_icon":1},{"id":"2588706234","title":"Alpha Cognition CEO Joins Titan Partners Virtual Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2588706234","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588706234?lang=en_us&edition=fundamental","pubTime":"2025-12-02 06:51","pubTimestamp":1764629471,"startTime":"0","endTime":"0","summary":"Alpha Cognition Inc., a commercial-stage biopharmaceutical company focused on therapies for neurodegenerative diseases, will participate in a virtual fireside chat hosted by Boris Peaker of Titan Partners. The event will take place on December 2, 2025, from 12:00 pm to 1:00 pm EST, with CEO Michael McFadden representing the company. The discussion will center on commercialization efforts and research initiatives to accelerate the adoption of Alpha Cognition's therapies.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alpha Cognition Inc. published the original content used to generate this news brief via Business Wire  on December 01, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nNDL4W6jWV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACOG"],"gpt_icon":0},{"id":"2585627469","title":"Analysts Offer Insights on Healthcare Companies: Co-Diagnostics (CODX), Stevanato Group (STVN) and Alpha Cognition Inc (ACOG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2585627469","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585627469?lang=en_us&edition=fundamental","pubTime":"2025-11-24 19:30","pubTimestamp":1763983822,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Co-Diagnostics (CODX – Research Report), Stevanato Group (STVN – ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-co-diagnostics-codx-stevanato-group-stvn-and-alpha-cognition-inc-acog-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-co-diagnostics-codx-stevanato-group-stvn-and-alpha-cognition-inc-acog-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","BK4082","BK4568","ACOG","STVN","BK4539","CODX","BK4581","HCSG","LABU","LU0029874061.USD","LU0128526141.USD","BK4585","XBI","BK4588","BK4137","XLV","BK4139"],"gpt_icon":0},{"id":"2583024765","title":"Alpha Cognition Reports $2.8 Million Revenue and Expanding ZUNVEYL Adoption in Q3 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2583024765","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583024765?lang=en_us&edition=fundamental","pubTime":"2025-11-14 22:47","pubTimestamp":1763131638,"startTime":"0","endTime":"0","summary":"Alpha Cognition Inc.  reported business updates for the third quarter of 2025, highlighting continued momentum in the commercialization of ZUNVEYL. Revenue for the quarter reached $2.8 million, consisting of $2.3 million in ZUNVEYL net product sales and $0.5 million in licensing revenue, reflecting strong sequential growth. Pharmacy orders grew by 102% compared to the previous quarter, with ZUNVEYL now reaching more than 600 nursing homes and the prescriber base exceeding 500 clinicians. The company reported pro forma cash of approximately $73.2 million following an equity raise in October, which is expected to provide about two years of operational runway. The company also retains access to a $75 million ATM facility.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nNDLWD829:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACOG"],"gpt_icon":0},{"id":"2583117085","title":"Alpha Cognition Q3 Sales $2.300M Beat $2.033M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2583117085","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583117085?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:04","pubTimestamp":1763067872,"startTime":"0","endTime":"0","summary":"Alpha Cognition (NASDAQ:ACOG) reported quarterly sales of $2.300 million which beat the analyst consensus estimate of $2.033 million by 13.16 percent.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48849806/alpha-cognition-q3-sales-2-300m-beat-2-033m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USJW.SI",".IXIC","QLD","PSQ","MNQmain","ACOG","QID","BK4139","NQmain","NVIW.SI","TSYW.SI","USAW.SI","SQQQ","TQQQ"],"gpt_icon":0},{"id":"2583511558","title":"Press Release: Alpha Cognition Inc. Reports Third Quarter 2025 Financial Results and Provides Operational Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2583511558","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583511558?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:00","pubTimestamp":1763067600,"startTime":"0","endTime":"0","summary":"--  ZUNVEYL Launch Momentum: Completed the second quarter of. commercialization, generating approximately $2.8 million in total revenue. --  Significant Growth: 102% quarterly increase in pharmacy orders, with. record prescription volumes achieved each month during the quarter.--  Expanding Prescriber Base: Q3 prescribers surpassed 500, representing. --  Disciplined Expense Management: Full-year operating spend guidance. reduced to $28--30 million; the Company expects operating profitability. --  Strong Balance Sheet: $35.4 million in cash and cash equivalents as of. September 30, 2025, excluding the October capital raise, which added. $37.8 million in net proceeds, resulting in total pro forma non-GAAP cash. Alpha Cognition Inc.   today announced its financial results for the third quarter ended September 30, 2025, and provided an operational update.$2.3 million in product sales and $0.5 million in business development. --  Selling, General & Administrative: Expenses were $6.9 million","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACOG"],"gpt_icon":0},{"id":"2579416111","title":"Press Release: Alpha Cognition (Nasdaq: ACOG) to Report Third Quarter 2025 Financial Results and Provide Business Update on Thursday, November 13, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2579416111","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579416111?lang=en_us&edition=fundamental","pubTime":"2025-10-30 20:33","pubTimestamp":1761827580,"startTime":"0","endTime":"0","summary":"Management to host conference call on Thursday, November 13, 2025 at 4:30pm ET. Alpha Cognition Inc. , a biopharmaceutical company dedicated to advancing treatments for neurodegenerative diseases, today announced that it will report its third quarter 2025 financial results and provide a business update on Thursday, November 13, 2025, at 4:30 p.m. ET, after market close.Following the release, management will host a conference call to review financial and operating results.To participate in the conference call, please use the dial-in information below:. - Participants can use Guest dial-in #s above and be answered by an operator OR click the Call me link for instant telephone access to the event. Call me link will be made active 15 minutes prior to scheduled start time.Alpha Cognition Inc. is a commercial stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease and Cognitive Impairment with mil","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNQmain","TM","SQQQ","BK4139","QID","BK4099","R","03160","TQQQ","BK4588","USAW.SI","BK4232","BK4604","BK4585","USJW.SI","TSYW.SI","BK4555","QLD","NQmain","NVIW.SI","PSQ","ACOG","BK4022",".IXIC"],"gpt_icon":1},{"id":"2579141370","title":"Alpha Cognition Inc. to Release Third Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2579141370","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579141370?lang=en_us&edition=fundamental","pubTime":"2025-10-30 20:30","pubTimestamp":1761827447,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alpha Cognition Inc. published the original content used to generate this news brief via Business Wire  on October 30, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nNDL29Csgh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACOG"],"gpt_icon":0},{"id":"2576385106","title":"Alpha Cognition Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2576385106","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576385106?lang=en_us&edition=fundamental","pubTime":"2025-10-20 20:34","pubTimestamp":1760963640,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ACOG/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 20, 2025 08:34 ET (12:34 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACOG"],"gpt_icon":0},{"id":"2576821851","title":"Alpha Cognition Inc. : H.c. Wainwright Cuts Target Price to $18 From $20","url":"https://stock-news.laohu8.com/highlight/detail?id=2576821851","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576821851?lang=en_us&edition=fundamental","pubTime":"2025-10-20 20:15","pubTimestamp":1760962547,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251020:nAZN4OLWB2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACOG","BK4139"],"gpt_icon":0},{"id":"2575422452","title":"Alpha Cognition Inc. to Present New Clinical Data on ZUNVEYL® (Benzgalantamine) and Cholinesterase Inhibitors at Upcoming Scientific Meetings","url":"https://stock-news.laohu8.com/highlight/detail?id=2575422452","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575422452?lang=en_us&edition=fundamental","pubTime":"2025-10-15 04:30","pubTimestamp":1760473822,"startTime":"0","endTime":"0","summary":"Alpha Cognition Inc. to Present New Clinical Data on ZUNVEYL  and Cholinesterase Inhibitors at Upcoming Scientific Meetings. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alpha Cognition Inc. published the original content used to generate this news brief via Business Wire  on October 14, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251014:nNDL36Z4zc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACOG"],"gpt_icon":0},{"id":"2573724056","title":"Alpha Cognition Inc. to Present New Clinical Data on ZUNVEYL® and Cholinesterase Inhibitors at ASCP Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2573724056","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573724056?lang=en_us&edition=fundamental","pubTime":"2025-10-06 20:30","pubTimestamp":1759753827,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alpha Cognition Inc. published the original content used to generate this news brief via Business Wire  on October 06, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nNDL473yR9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACOG","BK4139"],"gpt_icon":0},{"id":"2572513302","title":"Alpha Cognition Inc - Pricing of Oversubscribed Underwritten Public Offering of 5,600,000 Common Shares at $6.25 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2572513302","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572513302?lang=en_us&edition=fundamental","pubTime":"2025-10-01 11:14","pubTimestamp":1759288469,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nFWN3VH119:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACOG","BK4139"],"gpt_icon":0},{"id":"2572370696","title":"BRIEF-Alpha Cognition Announces Proposed Public Offering Of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2572370696","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572370696?lang=en_us&edition=fundamental","pubTime":"2025-10-01 06:20","pubTimestamp":1759270838,"startTime":"0","endTime":"0","summary":"BRIEF-Alpha Cognition Announces Proposed Public Offering Of Common SharesSept 30 (Reuters) - Alpha Cognition Inc ACOG.O:ALPHA COGNITION INC. ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON SHARESSource text: ID:nBw7yG141aFurther company coverage: ACOG.O ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250930:nFWN3VH12Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACOG"],"gpt_icon":0},{"id":"2572637779","title":"Alpha Cognition Plans Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2572637779","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572637779?lang=en_us&edition=fundamental","pubTime":"2025-10-01 06:01","pubTimestamp":1759269709,"startTime":"0","endTime":"0","summary":"Alpha Cognition (ACOG) said late Tuesday it plans to sell shares in an underwritten public offering.Investors can also buy pre-funded warrants in lieu, said the commercial-stage biopharmaceutical company.Shares were down over 12% in after-market activity.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ACOG","BK4139"],"gpt_icon":0},{"id":"2572723953","title":"Alpha Cognition announces common stock offering, no amount given","url":"https://stock-news.laohu8.com/highlight/detail?id=2572723953","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572723953?lang=en_us&edition=fundamental","pubTime":"2025-10-01 05:00","pubTimestamp":1759266014,"startTime":"0","endTime":"0","summary":"Alpha Cognition (ACOG) announced that it is proposing to offer and sell its common shares and, in lieu of common shares to certain investors, pre-f...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alpha-cognition-announces-common-stock-offering-no-amount-given-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alpha-cognition-announces-common-stock-offering-no-amount-given-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ACOG"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":31,"code":"91000000","status":"200"}]}}